|
Volumn 13, Issue 9, 2007, Pages 1008-1009
|
Therapy on trial
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ADALIMUMAB;
PARVOVIRUS VECTOR;
TUMOR NECROSIS FACTOR ALPHA;
BLEEDING;
COMBINED IMMUNODEFICIENCY;
GENE THERAPY;
HEAD AND NECK CANCER;
HEART MUSCLE ISCHEMIA;
HERPES SIMPLEX VIRUS;
HISTOPLASMA CAPSULATUM;
HUMAN;
IMMUNE DEFICIENCY;
INFECTION;
KIDNEY FAILURE;
LEUKEMIA;
LIVER INJURY;
LIVER TUMOR;
LONG TERM CARE;
MELANOMA;
NONHUMAN;
PARKINSON DISEASE;
PATIENT SAFETY;
PRIORITY JOURNAL;
RESPIRATORY FAILURE;
RHEUMATOID ARTHRITIS;
SHORT SURVEY;
VIRAL GENE DELIVERY SYSTEM;
VIRUS REPLICATION;
CHILD;
ETHICS, MEDICAL;
GENE THERAPY;
GENETIC VECTORS;
HUMANS;
RISK ASSESSMENT;
SEVERE COMBINED IMMUNODEFICIENCY;
|
EID: 34948876831
PISSN: 10788956
EISSN: 1546170X
Source Type: Journal
DOI: 10.1038/nm0907-1008 Document Type: Short Survey |
Times cited : (15)
|
References (0)
|